Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available

Since generics and biosimilars have entered the Russian market of medications, there are new trends in the general picture of drug prices and consumption. In the present study, we analyze these trends to enable the prediction of possible savings or redistribution of funds in the area of anticancer d...

Full description

Bibliographic Details
Main Authors: F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev
Format: Article
Language:Russian
Published: IRBIS LLC 2019-07-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/292